Endpoints News· @endpts · X·· 22 天前AI 评分42
AI 导读
总部位于巴塞尔的Windward Bio申请纳斯达克IPO,为两款源自中国的资产及内部研发提供资金。https://endpoints.news/windward-bio-files-for-nasdaq-ipo-to-fund-china-derived-assets-and-in-house-rd/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Basel-based Windward Bio filed for a Nasdaq IPO to fund two China-derived assets and in-house R&D. https://endpoints.news/windward-bio-files-for-nasdaq-ipo-to-fund-china-derived-assets-and-in-house-rd/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com